Funder
Japan Society for the Promotion of Science
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Molecular Biology,General Medicine,Pathology and Forensic Medicine
Reference47 articles.
1. Chiosea S, Agaimy A, Nagao T, et al. (2022) Salivary duct carcinoma. In: WHO Classification of Tumours Online, Head and Neck Tumours (WHO Classification of tumours series, 5th ed.; vol.9). https://tumourclassification.iarc.who.int/chapters/52. Accessed 19 June 2023.
2. Nakaguro M, Tada Y, Faquin WC et al (2020) Salivary duct carcinoma: Updates in histology, cytology, molecular biology, and treatment. Cancer Cytopathol 128:693–703. https://doi.org/10.1002/cncy.22288
3. Masubuchi T, Tada Y, Maruya S-i et al (2015) Clinicopathological significance of androgen receptor, HER2, Ki-67 and EGFR expressions in salivary duct carcinoma. Int J Clin Oncol 20:35–44. https://doi.org/10.1007/s10147-014-0674-6
4. Takase S, Kano S, Tada Y et al (2017) Biomarker immunoprofile in salivary duct carcinomas: clinicopathological and prognostic implications with evaluation of the revised classification. Oncotarget 8:59023–59035. https://doi.org/10.18632/oncotarget.19812
5. Fushimi C, Tada Y, Takahashi H et al (2018) A prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma. Ann Oncol 29:979–984. https://doi.org/10.1093/annonc/mdx771
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献